Abiopharma

🔍 Kale Aaron M. (Executive)

Company: Wendy's Co (WEN)

Report Date: 2026-08-12

Detailed Transactions and Holdings:

• Acquired 2,209 shares of Common Stock (Direct)
  Date: 2026-08-12 | Code: M | equity_swap_involved: 0 | shares_owned_after: 15,037.00 | transaction_form_type: 4 | Footnotes: F1
• Sold 599 shares of Common Stock at $8.66 per share (Direct)
  Date: 2026-08-12 | Code: F | equity_swap_involved: 0 | shares_owned_after: 14,438.00 | transaction_form_type: 4
• Sold 2,209 shares of Restricted Stock Units (Derivative)
  Date: 2026-08-12 | Code: M | equity_swap_involved: 0 | shares_owned_after: 13,736.00 | transaction_form_type: 4 | Footnotes: F2, F1, F3, F4, F4

Footnotes:

• F1: Each restricted stock unit represents a contingent right to receive one share of the Company's common stock.
• F2: With tandem dividend equivalent rights and tax withholding rights.
• F3: Includes 149 dividend equivalent units that had accrued on the restricted stock units.
• F4: The restricted stock units were granted on August 12, 2025 and vest in three equal installments on the first, second and third anniversaries of the grant date, subject to Mr. Kale's continued employment with the Company on the applicable vesting date. The first installment (including the related dividend equivalent units) vested on August 12, 2026.